AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback